853
Views
23
CrossRef citations to date
0
Altmetric
Review

The emerging role of type 2 inflammation in asthma

ORCID Icon, , , &
Pages 63-71 | Received 25 Sep 2020, Accepted 04 Dec 2020, Published online: 17 Dec 2020

References

  • Siddiqui S, Shikotra A, Richardson M, et al. Airway pathological heterogeneity in asthma: visualization of disease micro clusters using topological data analysis. J Allergy Clin Immunol. 2018;142:1457–1458.
  • Lin J, Huang N, Li J, et al. Cross-reactive antibodies against dust mite-derived enolase induce neutrophilic airway inflammation. Eur Respir J. 2020;1902375. doi:https://doi.org/10.1183/13993003.02375-2019
  • Gandhi NA, Gandhi NA, Bennett BL, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35–50.
  • Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001–1008.
  • Carr TF, Zeki AA, Kraft M. Eosinophilic and non eosinophilic asthma. Am J Respir Crit Care Med. 2018;197:22–37.
  • Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The belgian severe asthma registry (BSAR). Respir Med. 2014;108:1723–1732.
  • Perez-de-Llano L, Tran TN, Al-ahmad M, et al. Characterization of eosinophilic and non-eosinophilic severe asthma phenotypes and proportion of patients with these phenotypes in the International Severe Asthma Registry (ISAR). Am J Respir Crit Care Med. 2020;201:A4525.
  • Kubo MK. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278:162–172.
  • Akdis CA, Arkwright PD, Brüggen MC, et al. Type 2 immunity in the skin and lungs. Allergy. 2020;75(7):1582–1605.
  • Boonpiyathad T, Sözener ZC, Satitsuksanoa P, et al. Immunologic mechanisms in asthma. Semin Immunol. 2019;46:101333.
  • Peters MC, Wenzel SE. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. Lancet. 2020;395:371–383.
  • Ricci M, Rossi O, Bertoni M, et al. The importance of Th2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy. 1993;23:360–369.
  • Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50:975–991.
  • Walker JA, McKenzie ANJ. TH2 cell development and function. Nat Rev Immunol. 2018;18:121–133.
  • Del Prete GF, De Carli M, D’Elios M, et al. Allergen exposure induces the activation of allergen-specific TH2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol. 1993;23:1445–1449.
  • Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol. 1991;146(4):1169–1174.
  • Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL 3), IL 4, IL-5 and granulocyte/macrophage colony-stimulating-factor, in allergen-induced late-phase reactions in atopic subjects. J Exp Med. 1991;173:775–778.
  • Robinson D, Hamid Q, Ying S, et al. Predominant TH-like bronchoalveolar T-lymphocyte population in atopic asthma. New Engl J Med. 1992;326:298–304.
  • Lambrecht BN, Hammad H. The immunology of asthma. NatImmunol. 2015;16:45–56.
  • Parronchi P, Macchia D, Piccinni MP, et al. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci. 1991;88:4538–4542.
  • Schulten V, Tripple V, Sidney J, et al. Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy. J Allergy Clin Immunol. 2014;134:1076–1083.
  • Jones AC, Anderson D, Troy NM, et al. Rewiring of gene networks underlying mite allergen-induced CD4 + Th-cell responses during immunotherapy. Allergy. 2020;75(9):2330–2341.
  • Kopf M, Le Grost G, Bachmann M, et al. Disruption of the murine IL-4 gene blocks TH2 cytokine responses. Nature. 1993;362:245–248.
  • Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced TH2 response and IgE class witching in mice with disrupted Stat6 gene. Nature. 1996;380:630–633.
  • Okamoto M, Matsuda H, Joetham A, et al., Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol. 2009;183(5):2995.
  • Wang Z, Ji N, Chen Z, et al. MiR-1165-3p Suppresses Th2 Differentiation via Targeting IL-13 and PPM1A in a mouse model of allergic airway inflammation. Allergy Asthma Immunol Res. 2020;12(5):859–876.
  • Kondo M, Tezuka T, Ogawa H, et al. Lysophosphatidic acid regulates the differentiation of Th2 cells and its antagonist suppresses allergic airway inflammation. Int Arch Allergy Immunol. 2020;26:1–13.
  • Rosemberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol. 2007;119:1303–1310.
  • Wambre E, Bajzik V, DeLong JH, et al. A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. Sci Trans Med. 2017;9(401):EAAM9171.
  • Luce S, Chinthrajah S, Lyu SC, et al. Th2A and Th17 cell frequencies and regulatory markers as follow-up biomarker candidates for successful multi food oral immunotherapy. Allergy. 2020;75:1513–1516.
  • Hondowicz BD, An D, Schenkel JM, et al., Interleukin-2-dependent allergen-specific tissue-resident memory cells drive asthma. Immunity. 2016;44(1):155–166.
  • Shinoda K, Hirahara K, Iinuma T, et al. Thy1+IL-7+ lymphatic endothelial cells in iBALT provide a survival niche for memory T-helper cells in allergic airway inflammation. Proc Natl Acad Sci U S A. 2016;113:E2842–51.
  • Turner DL, Goldklang M, Cvetkovski F, et al. Biased generation and in situ activation of lung tissue-resident memory CD4T cells in the pathogenesis of allergic asthma. J Immunol. 2018;200:1561–1569.
  • Rahimi RA, Nepal K, Cetinbas M, et al. Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease. J Exp Med. 2020;217:e20190865.
  • Froidure A, Shen C, Gras D, et al. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy. 2014;69:1068–1076.
  • Yu S, Kim HY, Chang YJ, et al. Innate lymphoid cells and asthma. J Allergy Clin Immunol. 2014;133:943–950.
  • Klein Wolterink RG, Kleinjan A, van Nimwegen M, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol. 2012;42(5):1106–1116.
  • Smith SG, Chen R, Kjarsgaard M, et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol. 2016;137:75–86.
  • Vivier E, Artis D, Colonna M, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174:1054–1066.
  • Maggi L, Montaini G, Mazzoni A, et al. Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production. J Allergy Clin Immunol. 2017;139:964–76.e4.
  • Bartemes KR, Kephart GM, Fox SJ, et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014;134:671–8 e674.
  • Camelo A, Rosignoli G, Ohne Y, et al. IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Adv. 2017;1:577–589.
  • Liu S, Verma M, Michalec L, et al. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin. J Allergy Clin Immunol. 2018;141(1):257–268.
  • Christianson CA, Goplen NP, Zafar I, et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol. 2015;136:59–68.
  • Yu QN, Guo YB, Li X, et al. ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma. Allergy. 2018;73:1860–1870.
  • Chen R, Smith SG, Salter B, et al. Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma. Am J Respir Crit Care Med. 2017;196:700–712.
  • Walford HH, Lund SJ, Baum RE, et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. Clin Immunol. 2014;155:126–135.
  • Miljikovic D, Bassiouni A, Cooksley C, et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy. 2014;69:1154–1161.
  • Ishii T, Muroi M, Horiguchi K, et al. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics. Clin Exp Allergy. 2019;49:1624–1632.
  • Lim AI, Menegatti S, Bustamante J, et al., IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med. 2016;213(4):569–583.
  • Maggi L, Manuela C, Mazzoni A, et al. Plasticity and regulatory mechanisms of human ILC2 functions. Immunol Lett. 2020;S0165-2478(20):30367–30369. [Online ahead of print].
  • Huang Y, Guo L, Qiu J, et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells. Nat Immunol. 2015;16:161–169.
  • Iwamura C, Nakayama T. Role of CD1d- and MR1-restricted T Cells in asthma. Front Immunol. 2018;9:1942–1955.
  • Koh YI, Shim JU. Association between sputum natural killer T cells and eosinophilic airway inflammation in human asthma. Int Arch Allergy Immunol. 2014;153:239–248.
  • Nagata Y, Kamijuku H, Taniguchi M, et al. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int Arch Allergy Immunol. 2007;144(4):305–314.
  • Terashima A, Watarai H, Inoue S, et al., A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med. 2008;205(12):2727–2733.
  • Camelo A, Barlow JL, Drynan LF, et al. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J Gastroenterol. 2012;47(11):1198–1211.
  • Bourgeois E, Van LP, Samson M, et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol. 2009;39(4):1046–1055.
  • Fan X, Rudensky AY. Hallmarks of tissue-resident lymphocytes. Cell. 2016;164:1198–1211.
  • Lezmi G, Invariant Natural L-D-MA. Killer T cells and mucosal-associated invariant T cells in asthmatic patients. Front Immunol. 2018;9:1766–1775.
  • Wen T, Rothenberg ME. The regulatory function of eosinophils. Microbiol Spectr. 2016;MCHD-0020-2015. DOI:https://doi.org/10.1128/microbiolspec
  • Berek C. Eosinophils can more than kill. J Exp Med. 2018;215:1967–1969.
  • Abdala-Valencia H, Coden ME, Chiarella SE, et al. Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. J Leukoc Biol. 2018;104:95–108.
  • Broughton SE, Nero TL, Dhagat U, et al. The βc receptor family – structural insights and their functional implications. Cytokine. 2015;74:247–258.
  • Tachimoto H, Ebisawa M, Bochner BS. Cross-talk between integrins and chemokines that influences eosinophil adhesion and migration. Int Arch Allergy Immunol. 2002;128(Suppl 1):18–20.
  • O’ Sullivan JA, Bruce S, Bochner BS. Eosinophils and eosinophil-associated diseases: an update. J Allergy Clin Immunol. 2018;141:505–517.
  • Cherry WB, Yoon J, Bartemes KR, et al. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008;121:1484–1490.
  • Wong CK, Hu S, Cheung PF, et al., Thymic stromal lymphopoietin induces chemotactic and pro survival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol. 2010;43(3):305–315.
  • Jacobsen EA, Doyle AD, Colbert DC, et al. Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice. Allergy. 2015;70:1148–1159.
  • Dvorak AM, Estrella P, Ishizaka T. Vesicular transport of peroxidase in human eosinophilic myelocytes. Clin Exp Allergy. 1994;24:101–108.
  • Acharya KR, Ackerman SJ. Eosinophil granule proteins: form and function. J Biol Chem. 2014;289:17406–17415.
  • Yang D, Rosenberg HF, Chen Q, et al. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood. 2003;102(9):3396–3403.
  • Spencer LA, Melo RC, Perez SA, et al. Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc Natl Acad Sci USA. 2006;103:3333–3338.
  • Schmid-Grendelmeier P, Altznauer F, Fischer B, et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol. 2002;169(2):1021102–1021107.
  • Walsh ER, Thakar J, Stokes K, et al. Computational and experimental analysis reveals a requirement for eosinophil-derived IL-13 for the development of allergic airway responses in C57BL/6 mice. J Immunol. 2011;186(5):2936–2949.
  • Ravin KA, Loy M. The Eosinophil in Infection. Clin Rev Allergy Immunol. 2016;50(2):214–227.
  • Macfarlane AJ, Kon OM, Smith SJ, et al. Basophils, eosinophils, and mast cells in atopic and non atopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol. 2000;105:99–107.
  • Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699–1705.
  • Amin K, Janson C, Boman G, et al. The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in non allergic asthma. Allergy. 2005;60:1241–1247.
  • Balzar S, Chu HW, Strand M, et al. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med. 2005;171:431–439.
  • Bradding P, Arthur G. Mast cells in asthma – state of the art. Clin Exp Allergy. 2015;46:194–263.
  • Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med. 1997;155:1828.
  • Kardas G, Daszynska-Kardas A, Marynowski M, et al. Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target. Front Pharmacol. 2020;11:47–56.
  • Symowski C, Voehringer D. Interactions between innate lymphoid cells and cells of the innate and adaptive immune system. Front Immunol. 2017;8:1422–1430.
  • Oliphant CJ, Hwang YY, Walker JA, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity. 2014;41:283.
  • Halim TY, Steer CA, Matha L, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 2014;40:425–435.
  • Schwartz C, Khan AR, Floudas A, et al. ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control. J Exp Med. 2017;214:2507–2521.
  • Symowski C, Voehringer D. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Eur J Immunol. 2019;49:1421–1432.
  • Bando JK, Nussbaum JC, Liang HE, et al. Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung. J Leukoc Biol. 2013;94:877–884.
  • Motomura Y, Morita H, Moro K, et al. Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity. 2014;40:758–771.
  • Kim BS, Wang K, Siracusa MC, et al. Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol. 2014;193:3717–3725.
  • Roediger B, Kyle R, Tay SS, et al. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. J Allergy Clin Immunol. 2015;136:1653–1663.
  • Bouchery T, Kyle R, Camberis M, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:6970–6980.
  • Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204:253–258.
  • Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680.
  • Kitajima M, Lee HC, Nakayama T, et al. TSLP enhances the function of helper type 2 cells. Eur J Immunol. 2011;41(7):1862–1871.
  • Watanabe N, Hanabuchi S, Soumelis V, et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol. 2004;5(4):426–434.
  • Kashyap M, Rochman Y, Spolski R, et al. Thymic stromal lymphopoietin is produced by dendritic cells. J Immunol. 2011;187(3):1207–1211.
  • Elder MJ, Webster SJ, Williams DL, et al. TSLP production by dendritic cells is modulated by IL-1beta and components of the endoplasmic reticulum stress response. Eur J Immunol. 2016;46(2):455–463.
  • Tanaka J, Watanabe N, Kido M, et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy. 2009;39:89–100.
  • Gevaert E, Zhang N, Krysko O, et al. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J Allergy Clin Immunol. 2017;139:1849–1860.
  • Choi Y, Le Pham D, Lee DH, et al. Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma. Exp Mol Med. 2018;50:104–114.
  • Yang D, Chen Q, Su SB, et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med. 2008;205:79–90.
  • Choi Y, Kim YM, Lee HR, et al. Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma. Allergy. 2020;75:95–103.
  • Joubert P, Hamid Q. Role of airway smooth muscle in airway remodelling. J Allergy Clin Immunol. 2005;116(3):713–716.
  • Li LH, Lu B, Wu HK, et al. Apigenin inhibits TGF-β1-induced proliferation and migration of airway smooth muscle cells. Int J Clin Exp Pathol. 2015;8(10):12557–12563.
  • Corren J. Role of interleukin-13 in asthma. Curr Allergy Asthma Rep. 2013;13:415–420.
  • Boonpiyathad T, Satitsuksanoa P, Akdis M, et al. Il-10 producing T and B cells in allergy. Semin Immunol. 2019;44:101326.
  • Taylor A, Verhagen J, Akdis CA, et al. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol. 2004;135(1):73–82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.